Sedative-, hypnotic-, or anxiolytic- (SHA-) related disorders include SHA intoxication, SHA withdrawal, and SHA-use disorder. These disorders result from abuse of a class of medications known as ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and anti-anxiety medications in adolescents and young adults has increased sharply since 2001, according to researchers.

Fospropofol disodium injection, an intravenous sedative-hypnotic agent for sedation in adults undergoing diagnostic or therapeutic procedures, is closer to an FDA OK after the agency’s Advisory ...

The use of sedative-hypnotics during breast cancer chemotherapy puts women at risk of becoming dependent on them, say researchers reporting a review of almost 46,000 patients. The drugs, which include ...

Half of Americans Report Recent Rx Use, Says CDC Administration of a non-benzodiazepine sedative hypnotic (NBSH) does not increase the likelihood of having a low arousal phenotype for obstructive ...

Sedative-hypnotic drugs — commonly called "depressants" — slow down or "depress" the activity of the brain. The best known are barbiturates (Amytal, Nembutal, Seconal, phenobarbital) and ...

THE questions of when to use, which to use and what may be accomplished from sedative-hypnotic drugs are, at times, very perplexing. The recent introduction into therapy of several new groups of these ...

Metoclopramide is a central dopamine D2-receptor antagonist used as an antiemetic and gastroprokinetic agent in dogs and cats 1,2,3,4. It has been used experimentally in pigeons as an antiemetic agent ...